Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab

Neuroendocrine neoplasms (NEN) are a heterogeneous group of tumors, which can be histologically separated by primary location, proliferation rate and differentiation of tumor cells. The therapeutic options and outcome depend on grading, staging and resectability of the tumor. Established treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Stüven, Anna Kathrin, Wiedenmann, Bertram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524935/
https://www.ncbi.nlm.nih.gov/pubmed/31143376
http://dx.doi.org/10.18632/oncotarget.26906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524935/
https://www.ncbi.nlm.nih.gov/pubmed/31143376
http://dx.doi.org/10.18632/oncotarget.26906

Ejemplares similares